Savoir Faire Capital Management L.P. Has $5.18 Million Stock Position in The Clorox Company (NYSE:CLX)

Savoir Faire Capital Management L.P. trimmed its position in The Clorox Company (NYSE:CLX) by 44.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,815 shares of the company’s stock after selling 25,186 shares during the quarter. Clorox makes up 2.6% of Savoir Faire Capital Management L.P.’s portfolio, making the stock its 16th biggest position. Savoir Faire Capital Management L.P.’s holdings in Clorox were worth $5,183,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Mizuho Securities USA LLC boosted its position in shares of Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Nuance Investments LLC boosted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares in the last quarter. Van ECK Associates Corp boosted its position in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after purchasing an additional 120,716 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Clorox by 11.9% during the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock worth $109,483,000 after purchasing an additional 85,529 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 0.9 %

Clorox stock opened at $169.14 on Tuesday. The firm has a market capitalization of $20.94 billion, a PE ratio of 58.93, a P/E/G ratio of 3.10 and a beta of 0.41. The company’s 50-day moving average is $162.53 and its 200-day moving average is $147.73. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.21. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 EPS. Sell-side analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.89%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is 170.03%.

Analysts Set New Price Targets

CLX has been the topic of a number of recent analyst reports. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and raised their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Barclays raised their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Finally, DA Davidson raised their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $155.00.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.57% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.